Laboratorios Farmaceuticos ROVI (ROVI) — Capital Reinvestment Ratio

Latest as of September 2025: 0.24x

Laboratorios Farmaceuticos ROVI (ROVI) has a Capital Reinvestment Ratio of 0.24x as of September 2025, meaning it reinvests 0% of its operating cash flow (€73.37 Million) in capital expenditures (€17.62 Million). See ROVI FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

€73.37 Million
EUR

Capital Expenditures

€17.62 Million
EUR

Data as of

Sep 2025
Most recent filing

Laboratorios Farmaceuticos ROVI Capital Reinvestment Ratio (2006–2024)

This chart tracks Laboratorios Farmaceuticos ROVI's Capital Reinvestment Ratio across 18 annual periods.

Annual Capital Reinvestment Ratio for Laboratorios Farmaceuticos ROVI (2006–2024)

Year-by-year Capital Reinvestment Ratio for Laboratorios Farmaceuticos ROVI from 2006 to 2024. For live market cap and broader valuation context, see ROVI stock market capitalisation.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2024 0.45x €138.28 Million €62.22 Million ▼ -7.7%
2023 0.49x €113.25 Million €55.19 Million ▲ +125.3%
2022 0.22x €237.60 Million €51.39 Million ▼ -21.1%
2021 0.27x €149.44 Million €40.94 Million ▼ -67.6%
2020 0.85x €46.88 Million €39.69 Million ▼ -72.7%
2018 3.10x €8.53 Million €26.46 Million ▲ +180.5%
2017 1.11x €18.04 Million €19.94 Million ▲ +178.5%
2016 0.40x €45.53 Million €18.08 Million ▼ -41.4%
2015 0.68x €29.39 Million €19.90 Million ▼ -37.8%
2014 1.09x €23.00 Million €25.05 Million ▲ +31.6%
2013 0.83x €29.82 Million €24.68 Million ▲ +18.3%
2012 0.70x €19.61 Million €13.72 Million ▲ +6.2%
2011 0.66x €12.68 Million €8.35 Million ▲ +150.3%
2010 0.26x €21.19 Million €5.58 Million ▼ -15.2%
2009 0.31x €9.62 Million €2.99 Million ▼ -59.6%
2008 0.77x €12.66 Million €9.74 Million ▼ -92.5%
2007 10.19x €1.15 Million €11.73 Million ▲ +1846.2%
2006 0.52x €7.72 Million €4.04 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow